We are live on ! Find out more
PA

Profund Advisors Portfolio holdings

AUM $2.72B
1-Year Est. Return 47.27%
This Fund
S&P 500
This Quarter Est. Return
+15.99%
1 Year Est. Return
+47.27%
3 Year Est. Return
+155.16%
5 Year Est. Return
+217.35%
10 Year Est. Return
+932.28%
AUM
$2.57B
AUM Growth
+$240M
Cap. Flow
-$1.33M
Cap. Flow %
-0.05%
Top 10 Hldgs %
34.11%
Holding
1,211
New
84
Increased
525
Reduced
539
Closed
63

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$18.8M
2
LIN icon
Linde
LIN
+$15.3M
3
AVGO icon
Broadcom
AVGO
+$2.95M
4
AMD icon
Advanced Micro Devices
AMD
+$2.59M
5
HD icon
Home Depot
HD
+$1.46M

Top Sells

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$6.03M
2
MSFT icon
Microsoft
MSFT
+$5.38M
3
CVX icon
Chevron
CVX
+$4.36M
4
META icon
Meta Platforms (Facebook)
META
+$4.08M
5
AAPL icon
Apple
AAPL
+$3.64M

Sector Composition

Rank Sector Weight
1 Technology 42.5%
2 Healthcare 12.67%
3 Consumer Discretionary 11.07%
4 Communication Services 9.14%
5 Financials 5.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VALE icon
201
Vale
VALE
$62.9B
$1.69M 0.07%
138,726
-24,155
-15% -$326K
SRE icon
202
Sempra
SRE
$60.8B
$1.69M 0.07%
23,486
-1,958
-8% -$140K
HALO icon
203
Halozyme
HALO
$9.72B
$1.68M 0.07%
41,346
-1,558
-4% -$58.4K
UTHR icon
204
United Therapeutics
UTHR
$26.3B
$1.68M 0.07%
7,300
+35
+0.5% +$7.9K
CI icon
205
Cigna
CI
$76.6B
$1.62M 0.06%
4,473
-529
-11% -$174K
PINS icon
206
Pinterest
PINS
$12.4B
$1.62M 0.06%
46,679
+3,894
+9% +$142K
CRNX icon
207
Crinetics Pharmaceuticals
CRNX
$8.86B
$1.6M 0.06%
34,283
-5,851
-15% -$229K
SCHW
208
Charles Schwab
SCHW
$177B
$1.6M 0.06%
22,157
+673
+3% +$44.3K
INFY icon
209
Infosys
INFY
$45B
$1.6M 0.06%
89,189
-106
-0.1% -$2.06K
EXAS
210
DELISTED
Exact Sciences
EXAS
$1.6M 0.06%
23,130
+1,218
+6% +$77K
BSX icon
211
Boston Scientific
BSX
$65.8B
$1.59M 0.06%
23,181
-340
-1% -$21.9K
CB icon
212
Chubb
CB
$140B
$1.56M 0.06%
6,034
+144
+2% +$35.4K
DVN icon
213
Devon Energy
DVN
$51.9B
$1.56M 0.06%
31,126
-10,266
-25% -$456K
BBIO icon
214
BridgeBio Pharma
BBIO
$16.5B
$1.56M 0.06%
50,474
+4,127
+9% +$140K
MRSH
215
Marsh
MRSH
$86.3B
$1.56M 0.06%
7,572
+938
+14% +$187K
LMT icon
216
Lockheed Martin
LMT
$134B
$1.56M 0.06%
3,424
+283
+9% +$124K
BPMC
217
DELISTED
Blueprint Medicines
BPMC
$1.55M 0.06%
16,375
-4,253
-21% -$365K
ECL icon
218
Ecolab
ECL
$75.6B
$1.55M 0.06%
6,710
+45
+0.7% +$9.54K
WBA
219
DELISTED
Walgreens Boots Alliance
WBA
$1.55M 0.06%
71,415
-10,050
-12% -$223K
MDGL icon
220
Madrigal Pharmaceuticals
MDGL
$12.6B
$1.54M 0.06%
5,763
-1,397
-20% -$329K
ALKS icon
221
Alkermes
ALKS
$8.82B
$1.54M 0.06%
56,848
-8,367
-13% -$238K
D icon
222
Dominion Energy
D
$62.5B
$1.54M 0.06%
31,228
-2,601
-8% -$122K
CVS icon
223
CVS Health
CVS
$137B
$1.54M 0.06%
19,251
-2,718
-12% -$208K
KRYS icon
224
Krystal Biotech
KRYS
$9.88B
$1.52M 0.06%
8,553
-5,229
-38% -$726K
DYN icon
225
Dyne Therapeutics
DYN
$4.04B
$1.52M 0.06%
53,447
+26,485
+98% +$599K
7 8
9
10 11

Similar funds

MASUI
MIRAE ASSET SECURITIES (USA) INC. New York $2.72B AUM 36.56% 1-Year Est. Return
XL
XN LP New York $2.72B AUM 46.67% 1-Year Est. Return
MSL
Mackay Shields LLC New York $2.73B AUM 2.13% 1-Year Est. Return
CA
Cornerstone Advisors Asheville, North Carolina $2.72B AUM 22.17% 1-Year Est. Return
TAM
Timucuan Asset Management Jacksonville, Florida $2.72B AUM 4.95% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
GC
Giverny Capital Montreal, Quebec, Canada $2.73B AUM 14.09% 1-Year Est. Return
FNF
Fidelity National Financial Jacksonville, Florida $2.72B AUM 29.3% 1-Year Est. Return

Profund Advisors's Q1 2024 Portfolio in Review

As of Q1 2024, Profund Advisors held 1,211 positions worth $2.57B, up 10% from $2.33B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Profund Advisors's Q1 2024 filing shows 84 new, 525 increased, 539 reduced and 63 closed positions. Its largest new stake was Altimmune: 134,842 shares worth $1.37M. The largest sale was ExxonMobil, an estimated $6.03M.

By sector, the portfolio is most concentrated in Technology at 43% of assets, up from 40% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Profund Advisors's largest Q1 2024 buy was Altimmune: 134,842 shares worth $1.37M.
  • Profund Advisors added most to NVIDIA in Q1 2024, an estimated $18.8M increase.
  • Profund Advisors's biggest Q1 2024 reduction was ExxonMobil, cutting an estimated $6.03M.
  • Profund Advisors fully exited Karuna Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $2.18M.
  • Profund Advisors's ten largest holdings make up 34% of its $2.57B portfolio in Q1 2024.
  • Profund Advisors opened 84 new positions and closed 63 in Q1 2024.
  • Profund Advisors's portfolio value rose 10% quarter-over-quarter to $2.57B.

Based on Profund Advisors's 13F filing for Q1 2024, filed 8 May 2024.